 |
ProductsAntisoma has a diverse portfolio of products in development. Our products target tumours by several different mechanisms and are intended for the treatment of a range of cancers. 
Read more
|
Latest news
| 02/09/2010 | Annual Report and Accounts 2010 | |
| 29/07/2010 | Antisoma’s preliminary results for the year ended 30 June 2010 | |
| 14/06/2010 | Antisoma announces AS1413 and AS1411 presentations at EHA |
In focus
|
11/08/10 – Canaccord conference webcast | |
|
29/07/10 – Preliminary results webcast | |
|
23/06/10 – Piper Jaffray conference webcast |
Share price
| 5.62 GBp |  -0.37 |
| Date: | 03/09/2010 |
